512 — Grand Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$15.09bn
- HK$19.44bn
- HK$12.28bn
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement
Brief: Grand Pharmaceutical Says SIR-Spheres Y-90 Microsphere Injection US HCC Study Reaches Clinical Endpoint
Chinese business hired lobbying firm with ties to Don Jr, then scored a win in Washington
Chinese business hired lobbying firm with ties to Don Jr, then scored a win in Washington
Chinese firm hired lobbyists with ties to Don Jr, then scored a win in Washington
Brief: Grand Pharmaceutical Group Posts FY Revenue HKD 12,283.27 Million
Brief: Grand Pharmaceutical Group Says NMPA Approves GPN01020 For Phase II Clinical Trial
Tarsus rises as China approval unlocks $15 million milestone for eye drug
Brief: Grand Pharmaceutical Expects FY Profit Attributable HK$1.20 Bln-HK$1.25 Bln
Brief: Grand Pharmaceutical's Unit Enters Into Facility Agreement For Term Loan Facility Of Hk$0.8 Billion
Australia's Telix Pharmaceuticals rises on China acceptance of new drug application
Brief: Grand Pharmaceutical Says NDA Of RDC TLX591-CDX Accepted By NMPA
Brief: Grand Pharmaceutical Announces Acquisition By Hubei Yuanda
Brief: Grand Pharmaceutical Says Neffy Obtains Drug Registration Certificate From China's NMPA
Grand Pharmaceutical climbs on progress of drug for prostate cancer
Brief: Grand Pharmaceutical Says GPN01530 Approved For Clinical Trials In The United States